Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-15-010167
Filing Date
2015-05-14
Accepted
2015-05-14 16:13:36
Documents
1
Period of Report
2015-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3541
  Complete submission text file 0001437749-15-010167.txt   5232
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BARRIER THERAPEUTICS, INC. 600 COLLEGE ROAD EAST, SUITE 3200 PRINCETON NJ 08540
Business Address
VANLENT ANNE (Reporting) CIK: 0001229243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 15863004